IPO Boutique

Cognition Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Cognition Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Cognition Therapeutics, Inc.CGTX -
NASDAQ
$11.00-$13.00 $12.00 $12.153.77 million10/8/2021
B Riley, Oppenheimer
Co-Manager(s):
Health Care
Filing(s):

Filed 2021-07-19
Terms Added 2021-10-04



Cognition Therapeutics, Inc. Quote & Chart - Click for current quote - CGTX

About Cognition Therapeutics, Inc. (adapted from Cognition Therapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CGTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved